Cargando…
Improving skeletal muscle insulin sensitivity via beta(2)‐agonist administration: a promising strategy to counteract metabolic disease and muscle loss
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9321888/ https://www.ncbi.nlm.nih.gov/pubmed/35415892 http://dx.doi.org/10.1113/JP282992 |